Risk Stratification of Latent Tuberculosis Defined by Combined Interferon Gamma Release Assays

• Véronique Corbière,

  Affiliation Laboratory of Vaccinology and Mucosal Immunity, Université Libre de Bruxelles (U.L.B.) Brussels, Belgium

  ⨯
• Gaelle Pottier,

  Affiliation Laboratory of Vaccinology and Mucosal Immunity, Université Libre de Bruxelles (U.L.B.) Brussels, Belgium

  ⨯
• Florence Bonkain,

  Affiliation Department of Nephrology, Hôpital Erasme, Université Libre de Bruxelles (U.L.B.) Brussels, Belgium

  ⨯
• Kinda Schepers,

  Affiliation Immunodeficiency Unit, Hôpital Erasme, Université Libre de Bruxelles (U.L.B.) Brussels, Belgium

  ⨯
• Virginie Verscheure,

  Affiliation Laboratory of Vaccinology and Mucosal Immunity, Université Libre de Bruxelles (U.L.B.) Brussels, Belgium

  ⨯
• Sophie Lecher,

  Affiliations INSERM, U1019, Lille, France, CNRS, UMR8204, Lille, France, Université de Lille Nord de France, Institut Pasteur de Lille, Lille, France, Center for Infection and Immunity of Lille, Lille, France

  ⨯
• T. Mark Doherty,

  Affiliation Department of Tuberculosis Immunology, Statens Serum Institute, Copenhagen, Denmark

  ⨯
• Camille Locht,

  Affiliations INSERM, U1019, Lille, France, CNRS, UMR8204, Lille, France, Université de Lille Nord de France, Institut Pasteur de Lille, Lille, France, Center for Infection and Immunity of Lille, Lille, France

  ⨯
• Françoise Mascart

  * E-mail: fmascart@ulb.ac.be

  Affiliations Laboratory of Vaccinology and Mucosal Immunity, Université Libre de Bruxelles (U.L.B.) Brussels, Belgium, Immunobiology Clinic, Hôpital Erasme, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium

  ⨯